News Takeda gets return on Ariad buy with approval of brigatinib But Japanese pharma bracing for US patent expiry on blockbuster Velcade
Views & Analysis Non-profit model for childhood cancer drugs Charities must work to help pharma and academia prioritise and accelerate paediatric treatments.
News Government wasted £1.3 billion on Cancer Drugs Fund, says st... The £1.3 billion of public expenditure on the old Cancer Drugs Fund (CDF) did not deliver value to patients or society, according to a new study.
News AstraZeneca's Cambridge R&D site build running years late Building not operational until 2019, says CEO
Views & Analysis Take a breath - this could be the definitive cancer screenin... Can breath be the basis for the ultimate cancer screening tool?
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
